Position in LLY
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$24,404,803
+$5,619,422 QoQ
Shares Held
20,347
-0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
#813
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesley Taft & Associates LLC holds $123,067,788 across 10 Drug Manufacturers - General names. LLY ranks #2 (19.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
209,735 | $53,266,397 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
20,347 | $24,404,803 | |
| 3 | AZN |
Astrazeneca PLC
|
81,276 | $15,411,554 | |
| 4 | MRK |
Merck & Co., Inc.
|
55,810 | $7,171,585 | |
| 5 | AMGN |
Amgen Inc
|
18,897 | $6,842,981 | |
| 6 | NVS |
Novartis AG
|
32,410 | $5,079,295 | |
| 7 | ABBV |
AbbVie Inc.
|
19,924 | $5,013,674 | |
| 8 | PFE |
Pfizer Inc
|
194,317 | $4,679,152 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,404,803 | 20,347 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $18,785,381 | 20,424 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $24,116,895 | 22,441 | Shares | Other | 2026-01-14 | |
| 2025-09-30 | $15,964,249 | 20,923 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $17,774,843 | 22,802 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $19,024,836 | 23,035 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $17,233,356 | 22,323 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $19,829,995 | 22,383 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $20,419,035 | 22,553 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $16,640,564 | 21,390 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $12,541,523 | 21,515 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $9,480,881 | 17,651 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $8,710,365 | 18,573 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $6,901,711 | 20,097 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $7,498,988 | 20,498 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $7,461,301 | 23,075 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $7,439,457 | 22,945 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $6,513,485 | 22,745 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $6,279,861 | 22,735 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $5,237,903 | 22,670 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $5,107,967 | 22,255 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $4,137,128 | 22,145 | Shares | Sole | 2021-04-06 | |
| 2020-12-31 | $3,696,751 | 21,895 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $3,304,546 | 22,325 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $3,813,080 | 23,225 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $3,140,620 | 22,640 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||